The SPEARHEAD-1 trial of afamitresgene autoleucel (afami-cel [formerly ADP-A2M4]): Pooled analysis of cytokine release syndrome across cohorts in patients with advanced synovial sarcoma
D'Angelo, Sandra P., Ganjoo, Kristen N., Blay, Jean-Yves, Valverde, Claudia, Araujo, Dejka M., Abdul Razak, Albiruni Ryan, Le Cesne, Axel, Schuetze, Scott, Wagner, Michael J, Attia, Steven, Forcade, Edouard, Druta, Mihaela, Pollack, Seth, Bai, Jane, Lunt, Colin, Sun, Amy, Yule, Murray, McAlpine, Cheryl, Williams, Dennis, Van Tine, Brian Andrew
Published in Journal of clinical oncology (01.06.2023)
Published in Journal of clinical oncology (01.06.2023)
Get full text
Journal Article
Abstract A038: Enrollment of pediatric and adolescent patients with MAGE-A4+ advanced synovial sarcoma into cohort 2 of SPEARHEAD-1: a phase 2 trial of afamitresgene autoleucel (“afami-cel” [formerly ADP-A2M4])
Lunt, Colin, D’Angelo, Sandra P., Razak, Albiruni Ryan Abdul, Wagner, Michael J., Van Tine, Brian A., Ganjoo, Kristen, Blay, Jean-Yves, Araujo, Dejka M., Agulnik, Mark, Glod, John W., Van Winkle, Erin, Elefant, Erica, Biswas, Swethajit, Williams, Dennis, Le Cesne, Axel
Published in Clinical cancer research (15.09.2022)
Published in Clinical cancer research (15.09.2022)
Get full text
Journal Article